Congress Has 100 Days to Act

The medical device tax will go back into effect at the end of this year.

As the clock has continued to tick, we have heard voices across the country speak out against this tax.

We’ve heard from patient leaders like Tracey Dedering, who hope that lawmakers get rid of this tax so cancer “thrivers” can get the treatments they need. We’ve heard from medical professionals, like the American Dental Association, who are worried about the effects of device tax on patient care, innovation and cost. We’ve heard from members of the media, including the Wall Street Journal editorial board, who recognize that the device tax is a “nasty tax on medical innovation.” And we’ve heard from bipartisan lawmakers – nearly 300 of them! – who agree that it is time to fully repeal this tax once and for all.

So today as we begin the 100-day countdown, we as advocates – and all the voices who have joined us over the past year – must recommit ourselves to the fight for medical innovation. The efforts we have seen from our lawmakers, while important, will only be able to protect jobs and medical innovation if legislation is passed by December 31st.

Make sure your lawmakers understand the urgent need for action: send your letter now.

Click here to take action.

More Articles

Support the FIND Act to Increase Access to Innovative Diagnostics

August 24, 2021

Through exciting innovations in diagnostic radiopharmaceuticals, doctors are finding new ways to diagnose and monitor conditions such as…

Read More

Real Risks of Unregulated Third-Party Servicing

August 4, 2021

Medical imaging has revolutionized healthcare from the start but especially over the past 30 years. Today, patients and…

Read More

Patients Don’t Need Extra Health Scares

April 15, 2021

My first health scare came when I was 41. Following my doctor’s advice, I began mammogram screenings at…

Read More

April is Parkinson’s Disease Awareness Month

April 13, 2021

April is Parkinson’s Disease Awareness Month! While Parkinson’s has many symptoms, perhaps one of the most well-known indications…

Read More